GlaxoSmithKline has been sued, with the Plaintiff claiming that that the anti-diabetes drug Avandia contributed to the death of a 60-year-old man.
Larry Stanford died May 21, 2007. That was the date of publication of a report in The New England Journal of Medicine claiming that Avandia may increase patients' risk for a heart attack. The lawsuit claims Glaxo knew of the dangers of the drug and continued to sell it to patients, including Stanford, who died of a heart attack.The lawsuit was filed in the United States District Court for the Eastern District of Texas. Stephen Drinnon of the Drinnon Law Firm filed the suit.